Korea Advanced Institute of Science and Technology
发明人:
申请号：
EP18883309.9
公开号：
EP3718549A1
申请日:
2018.11.01
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a novel pharmaceutical composition for the treatment of dystonia or relieving pain caused by myotonic condition in a subject suffering from dystonia. Particularly, the present invention provides a pharmaceutical composition for treating dystonia or relieving pain caused by dystonia comprising a serotonin receptor 5-HT2A inhibitor as an active ingredient.
